Solventum to acquire Acera Surgical for $850m.

Solventum, an American health care company, agreed to acquire Acera Surgical, a bioscience company that develops fully synthetic, electrospun fiber-based scaffolds for regenerative soft-tissue repair, for $850m. "Regenerative wound care is an exciting and fast-growing space, and Acera has innovative technology to meet a significant unmet need in acute wound care. Expanding our advanced wound care portfolio into the high-growth synthetic tissue matrices category complements solutions within our existing portfolio and enhances the options our specialized commercial team can provide doctors, nurses, and decision makers within acute care settings," Bryan Hanson, Solventum CEO.